Cluster Analysis of Fecal Incontinence Symptoms: Associations With Anorectal Physiology and Quality of Life
- Mohsin F. Butt,
- ,
- Isuzu Meyer,
- William D. Chey,
- William E. Whitehead,
- Holly E. Richter
- Mayo Clinic Rochester, MN,
- Nottingham University Hospitals NHS Trust,
- ,
- University of Alabama at Birmingham,
- University of Michigan, Ann Arbor,
- University of North Carolina at Chapel Hill
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Abstract
<p>Background & Aims The contributions of bowel disturbances and anorectal dysfunctions to fecal incontinence (FI) remain unclear. Based on defecatory awareness, the classification into urge vs passive FI overlooks other factors (eg, leakage volume). This study examined relationships among FI characteristics (stooling sensation, volume, consistency), bowel movements (BMs), and anorectal neurophysiology; evaluated their effect on quality of life (QoL); and identified clinical phenotypes. Methods Patients completed a 2-week bowel diary, questionnaires, and anorectal manometry. BM and FI characteristics were used for cluster analysis. Results Over 2 weeks, 268 patients (88% women) had a mean of 28.2 BMs (standard deviation, 15.2) and 19.7 FI episodes (standard deviation, 15.7). Patients >74 years had more frequent FI ( P = .01), more solid-FI episodes ( P = .008), better FI-QoL scores ( P ≤ .02), and lower anorectal pressures ( P ≤ .002) than those <58 years. Solid FI was associated with hard (Bristol Stool Form [BSF] 1–2) stools ( r = 0.17; P = .006) and normal (BSF 3–4) stools ( r = 0.30; P < .001) and inversely with anal resting pressure ( r = −0.25; P < .001) and squeeze increment ( r = −0.15; P = .02). Loose (BSF 5–7) stools were associated with liquid FI and urge FI ( r ≈ 0.3; P < .001). Urge FI was associated with poorer FI-QoL scores ( P < .001). Passive FI was associated with the frequency of normal stools ( r = 0.16; P = .009) and lower anal resting pressure ( r = −0.15; P = .02). Cluster analysis identified 4 distinct phenotypes, 2 characterized by passive and 2 by combined (urge-passive) FI. Conclusions FI characteristics were weakly but significantly associated with BMs and anorectal functions. Diary-captured stool and FI patterns identified 4 phenotypes associated with FI-based QoL and anorectal function. This stratification will likely facilitate the management of FI. ( ClinicalTrials.gov</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 1981-1994 (14 pages)Journal (Volume, Issue Number)
Clinical Gastroenterology and Hepatology (Volume 24, Issue 7)Publication milestones
- Accepted/In press - 2026
- Published - 07/2026
Publication status
Published - 07/2026
ISSN
1542-3565Publication IDs
- Scopus: 105027678681
- PubMed: 41297739
Publication metrics
Metrics
Fractional count
1
Fractional count
0.08
Fractional count
11
Fractional count
0.92
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
5
Citation count
7
Funding Details
Conflicts of interest These authors disclose the following: Adil E. Bharucha jointly holds a patent for the Medspira portable anorectal manometry device used in this study; Adil E. Bharucha and Mayo Clinic have contractual rights to receive royalties from the licensing of this technology; Mayo Clinic holds equity in the company to which the technology is licensed; This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies; Adil E. Bharucha is a consultant for BeCapio; jointly holds a patent with Minnesota Medical Technologies (receives royalties); jointly holds patents with Medtronic (no royalties); and has received research grants from the National Institutes of Health. William D. Chey is a consultant for Ardelyx, Atmo, Biomerica, Gemelli, Nestle, Phathom, Redhill, Salix/Valeant, Takeda, and Vibrant; has received grants or research funding from Commonwealth Diagnostics and Bausch; has been offered stock options from Coprata, Dieta, Evinature, FoodMarble, Kiwi Bioscience, and Modify Health; is a board member or advisory panel member in the American College of Gastroenterology, the International Foundation for Gastrointestinal Disorders, and the Rome Foundation; and has a patent for the rectal expulsion device. Holly E. Richter has received research grants from Cosm Medical, Reia, Patient-Centered Outcomes Research Institute, National Institute of Child Health and Human Development, and National Institute of Diabetes and Digestive and Kidney Diseases; is a member of the data and safety monitoring board for BlueWind Medical, Veristat, and Juniper Biomedical; receives royalties from UpToDate; is a member of the board of directors for the WorldWide Fistula Fund and the SOLACE Foundation; serves as a consultant for Neomedic, Coloplast, Palette Life Science, Laborie, Moremmé, International Consulting Associates, Axena Health, and Eli Lilly; receives reimbursement as an editor of the International Urogynecology Journal; and has been a continuing medical education speaker for Symposia Medicus. Jan Busby-Whitehead has research grants from the Health Resources and Services Administration, National Institute on Aging, and National Institute of Diabetes and Digestive and Kidney Diseases; is a member of the board of directors for the American Geriatrics Society and the American Geriatrics Society Health in Aging Foundation; and has received editor reimbursement from Cambridge University Press. William E. Whitehead has received research grants from the National Institutes of Health; and has received editor reimbursement from the Rome Foundation. The remaining authors disclose no conflicts.
We are grateful to our patients for participating in this study and to all the investigators. June Oshiro, PhD, ELS, Mayo Clinic, provided editorial suggestions on an earlier draft of the manuscript. Mohsin F. Butt (Formal analysis: Lead; Writing – original draft: Lead; Writing – review & editing: Equal) Satish S.C. Rao (Conceptualization: Lead; Funding acquisition: Lead; Investigation: Equal; Methodology: Lead; Writing – review & editing: Equal) Isuzu Meyer (Investigation: Equal; Writing – review & editing: Supporting) William D. Chey (Investigation: Equal; Writing – review & editing: Equal) William E. Whitehead (Conceptualization: Lead; Funding acquisition: Lead; Investigation: Equal; Methodology: Lead; Project administration: Equal) Holly E. Richter (Investigation: Equal; Writing – review & editing: Equal) Stacy B. Menees (Investigation: Equal; Writing – review & editing: Supporting) Jan Busby-Whitehead (Writing – review & editing: Supporting) Ramesh Lamichhane (Formal analysis: Equal; Writing – review & editing: Supporting) Jun Chen (Formal analysis: Equal; Writing – review & editing: Supporting) Frank A. Hamilton (Conceptualization: Lead; Methodology: Equal; Project administration: Equal) Adil E. Bharucha, MD (Conceptualization: Lead; Funding acquisition: Lead; Investigation: Lead; Methodology: Lead; Project administration: Lead; Writing – original draft: Lead; Writing – review & editing: Lead)
Funding This study is supported by the United States Public Health Service , National Institutes of Health Grants U01 DK 115575 to Adil E. Bharucha, William D. Chey, Satish S.C. Rao, Holly E. Richter, and Jan Busby-Whitehead.
FundersFunding number
NICHD
-MC
-TPUSA
-NIAMDD
-HRSA
-Eli Lilly and Company
-RF
-AGS
-IFFGD
-PCORI
-United States Public Health Service
-HiAF
-NIA
-ACG
-USNIH
U01 DK 115575
